Eurofins Scient (OTCMKTS:ERFSF) Shares Up 3.1% – Time to Buy?

Shares of Eurofins Scient (OTCMKTS:ERFSFGet Free Report) were up 3.1% on Monday . The stock traded as high as $73.8220 and last traded at $73.8220. Approximately 924 shares changed hands during trading, a decline of 38% from the average daily volume of 1,485 shares. The stock had previously closed at $71.6120.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on ERFSF shares. Citigroup reaffirmed a “neutral” rating on shares of Eurofins Scient in a research note on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a research report on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Check Out Our Latest Research Report on Eurofins Scient

Eurofins Scient Trading Up 3.8%

The firm has a 50-day moving average of $69.96 and a 200 day moving average of $72.77. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

Read More

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.